108 related articles for article (PubMed ID: 6419386)
21. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
22. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
[TBL] [Abstract][Full Text] [Related]
23. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
[TBL] [Abstract][Full Text] [Related]
24. Sequence-based typing of HLA-A gene in 930 patients with nasopharyngeal carcinoma in Hunan province, southern China.
Tian W; Zhu FM; Wang WY; Cai JH; Zhang W; Li LX; Liu KL; Jin HK; Wang F
Tissue Antigens; 2015 Jul; 86(1):15-20. PubMed ID: 25940993
[TBL] [Abstract][Full Text] [Related]
25. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
26. Linkage disequilibrium between the HLA-B14 subdivisions and HLA-A, DR and properdin factor B alleles.
Darke C
Tissue Antigens; 1984 Jan; 23(1):68-71. PubMed ID: 6583877
[TBL] [Abstract][Full Text] [Related]
27. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
28. Human leukocyte antigens -A, -B, -C, and -DR and nasopharyngeal carcinoma in northern China.
Zhu XN; Chen R; Kong FH; Liu W
Ann Otol Rhinol Laryngol; 1990 Apr; 99(4 Pt 1):286-7. PubMed ID: 2327697
[TBL] [Abstract][Full Text] [Related]
29. IgG and IgA antibodies to Epstein-Barr virus in nasopharyngeal carcinoma patients.
Gong SH; Lynn TC; Yang CS
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Mar; 11(1):8-15. PubMed ID: 211015
[TBL] [Abstract][Full Text] [Related]
30. HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales.
Darke C; Guttridge MG; Thompson J; McNamara S; Street J; Thomas M
Exp Clin Immunogenet; 1998; 15(2):69-83. PubMed ID: 9691201
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
[TBL] [Abstract][Full Text] [Related]
32. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
33. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between nasopharyngeal carcinoma (NPC) and HLA in Hunan Province].
Zhang JZ
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):170-2. PubMed ID: 3017660
[TBL] [Abstract][Full Text] [Related]
35. Proper use of serum antibody titres against Epstein-Barr virus in nasopharyngeal carcinoma: IgA/virus capsid antigen for diagnosis and EBV-related nuclear antigen-2 for follow-up.
Shimakage M; Dezawa T; Chatani M
Acta Otolaryngol; 2000 Jan; 120(1):100-4. PubMed ID: 10779195
[TBL] [Abstract][Full Text] [Related]
36. [HLA typing of nasopharyngeal carcinoma in Hunan province].
Yi YN
Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):267-9. PubMed ID: 3266851
[TBL] [Abstract][Full Text] [Related]
37. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
Chen X; Cai Y; Sun N
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(1):6-9. PubMed ID: 8031607
[TBL] [Abstract][Full Text] [Related]
38. HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen.
Aribi M; Moulessehoul S; Benabadji AB; Kendoucitani M
BMC Genet; 2004 Aug; 5():24. PubMed ID: 15331022
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
40. [HLA A-B and DR in dilated myocardiopathies].
Komajda M; Raffoux C; Salame E; Colombani J; Grosgogeat Y; Cabrol C; Dausset J
Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1233-7. PubMed ID: 3120659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
